The Post Office has announced plans to sell off its remaining directly-owned branches, putting around 1,000 employees at risk ...

Eisai/Biogen’s Leqembi (lecanemab) was fully approved in the US in July 2023, and Eli Lilly’s Kisunla (donanemab) in July ...

Key points A 47-year-old French-speaking woman of African descent presented to the emergency department with a 1-week history of severe foot pain and difficulty walking. For the preceding 2 months she ...

Team IMPACT, an non-profit group that joins colleges with children who have serious illnesses and disabilities, paired 12 ...

Individuals who live in areas with a higher social vulnerability index (SVI) have an increased risk for incident Alzheimer disease (AD) and a faster rate of cognitive decline.

Similar to many of my colleagues in medicine, I see firsthand how vitally important access to affordable medication is for ...